In addition, Yi et al., give a novel mechanistic basis for OPN influence on sorafenib sensitivity in AML, especially in Fms-like tyrosine kinase-3 internal tandem duplication (FLT3-ITD) mutated AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.